1. Home
  2. CUE vs RFM Comparison

CUE vs RFM Comparison

Compare CUE & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.31

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Logo RiverNorth Flexible Municipal Income Fund Inc.

RFM

RiverNorth Flexible Municipal Income Fund Inc.

HOLD

Current Price

$13.98

Market Cap

86.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
RFM
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.6M
86.2M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
CUE
RFM
Price
$0.31
$13.98
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
1.3M
20.7K
Earning Date
11-12-2025
01-01-0001
Dividend Yield
N/A
9.74%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,100,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$25.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.23
$12.89
52 Week High
$1.75
$16.41

Technical Indicators

Market Signals
Indicator
CUE
RFM
Relative Strength Index (RSI) 33.41 39.08
Support Level $0.23 $13.86
Resistance Level $0.33 $14.17
Average True Range (ATR) 0.05 0.09
MACD -0.00 -0.01
Stochastic Oscillator 27.03 24.65

Price Performance

Historical Comparison
CUE
RFM

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: